http://www.researchmoz.com Wed, 18 Jul 2012 12:20:54 +0000 en hourly 1 http://wordpress.org/?v=3.3.1http://www.researchmoz.com/suvorexant--comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/suvorexant--comprehensive-patent-search-report.html#commentsWed, 03 Apr 2013 00:00:00 -0500adminhttp://www.researchmoz.com/suvorexant--comprehensive-patent-search-report.html
Original Post Suvorexant - Comprehensive patent search
source Researchmoz]]>
Original Post Suvorexant - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/suvorexant--comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/insulin-aspart--comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/insulin-aspart--comprehensive-patent-search-report.html#commentsWed, 03 Apr 2013 00:00:00 -0500adminhttp://www.researchmoz.com/insulin-aspart--comprehensive-patent-search-report.html
Original Post Insulin Aspart - Comprehensive patent search
source Researchmoz]]>
Original Post Insulin Aspart - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/insulin-aspart--comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/clindamycin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/clindamycin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/clindamycin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Clindamycin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Clindamycin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/clindamycin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/ceftriaxone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/ceftriaxone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/ceftriaxone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Ceftriaxone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Ceftriaxone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/ceftriaxone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/cefazolin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/cefazolin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/cefazolin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Cefazolin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Cefazolin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/cefazolin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/bendamustine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/bendamustine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/bendamustine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Bendamustine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Bendamustine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/bendamustine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/dexmedetomidine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/dexmedetomidine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/dexmedetomidine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Dexmedetomidine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/dexmedetomidine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/axitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/axitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/axitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Axitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Axitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/axitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/canagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/canagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/canagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Canagliflozin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Canagliflozin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/canagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/dapagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/dapagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 11 Feb 2013 00:00:00 -0600adminhttp://www.researchmoz.com/dapagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Dapagliflozin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Dapagliflozin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/dapagliflozin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/vemurafenib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/vemurafenib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/vemurafenib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Vemurafenib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Vemurafenib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/vemurafenib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/colesevelam-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/colesevelam-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/colesevelam-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Colesevelam - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Colesevelam - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/colesevelam-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/rifaximin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/rifaximin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/rifaximin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Rifaximin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Rifaximin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/rifaximin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/nevirapine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/nevirapine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/nevirapine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Nevirapine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Nevirapine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/nevirapine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/liraglutide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/liraglutide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/liraglutide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Liraglutide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Liraglutide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/liraglutide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/vilazodone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/vilazodone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/vilazodone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Vilazodone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Vilazodone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/vilazodone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/hexylaminolevulinic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/hexylaminolevulinic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/hexylaminolevulinic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Hexylaminolevulinic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Hexylaminolevulinic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/hexylaminolevulinic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/treprostinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/treprostinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/treprostinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Treprostinil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Treprostinil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/treprostinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/vemurafenib-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/vemurafenib-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/vemurafenib-comprehensive-patent-search-report.html
Original Post Vemurafenib - Comprehensive patent search
source Researchmoz]]>
Original Post Vemurafenib - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/vemurafenib-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/colesevelam-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/colesevelam-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/colesevelam-comprehensive-patent-search-report.html
Original Post Colesevelam - Comprehensive patent search
source Researchmoz]]>
Original Post Colesevelam - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/colesevelam-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/rifaximin-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/rifaximin-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/rifaximin-comprehensive-patent-search-report.html
Original Post Rifaximin - Comprehensive patent search
source Researchmoz]]>
Original Post Rifaximin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/rifaximin-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/nevirapine-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/nevirapine-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/nevirapine-comprehensive-patent-search-report.html
Original Post Nevirapine - Comprehensive patent search
source Researchmoz]]>
Original Post Nevirapine - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/nevirapine-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/liraglutide-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/liraglutide-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/liraglutide-comprehensive-patent-search-report.html
Original Post Liraglutide - Comprehensive patent search
source Researchmoz]]>
Original Post Liraglutide - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/liraglutide-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/vilazodone-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/vilazodone-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/vilazodone-comprehensive-patent-search-report.html
Original Post Vilazodone - Comprehensive patent search
source Researchmoz]]>
Original Post Vilazodone - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/vilazodone-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/hexylaminolevulinic-acid-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/hexylaminolevulinic-acid-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/hexylaminolevulinic-acid-comprehensive-patent-search-report.html
Original Post Hexylaminolevulinic Acid - Comprehensive patent search
source Researchmoz]]>
Original Post Hexylaminolevulinic Acid - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/hexylaminolevulinic-acid-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/treprostinil-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/treprostinil-comprehensive-patent-search-report.html#commentsFri, 23 Nov 2012 00:00:00 -0600adminhttp://www.researchmoz.com/treprostinil-comprehensive-patent-search-report.html
Original Post Treprostinil - Comprehensive patent search
source Researchmoz]]>
Original Post Treprostinil - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/treprostinil-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/lopinavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/lopinavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lopinavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Lopinavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Lopinavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/lopinavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/fosamprenaivr-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/fosamprenaivr-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/fosamprenaivr-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Fosamprenaivr - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Fosamprenaivr - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/fosamprenaivr-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/ruxolitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/ruxolitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/ruxolitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Ruxolitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Ruxolitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/ruxolitinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/lixisenatide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/lixisenatide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lixisenatide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Lixisenatide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Lixisenatide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/lixisenatide-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/bivalirudin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/bivalirudin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/bivalirudin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Bivalirudin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Bivalirudin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/bivalirudin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/lopinavir-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/lopinavir-comprehensive-patent-search-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lopinavir-comprehensive-patent-search-report.html
Original Post Lopinavir - Comprehensive patent search
source Researchmoz]]>
Original Post Lopinavir - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/lopinavir-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/fosamprenaivr-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/fosamprenaivr-comprehensive-patent-search-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/fosamprenaivr-comprehensive-patent-search-report.html
Original Post Fosamprenaivr - Comprehensive patent search
source Researchmoz]]>
Original Post Fosamprenaivr - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/fosamprenaivr-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/ruxolitinib-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/ruxolitinib-comprehensive-patent-search-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/ruxolitinib-comprehensive-patent-search-report.html
Original Post Ruxolitinib - Comprehensive patent search
source Researchmoz]]>
Original Post Ruxolitinib - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/ruxolitinib-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/lixisenatide-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/lixisenatide-comprehensive-patent-search-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lixisenatide-comprehensive-patent-search-report.html
Original Post Lixisenatide - Comprehensive patent search
source Researchmoz]]>
Original Post Lixisenatide - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/lixisenatide-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/bivalirudin-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/bivalirudin-comprehensive-patent-search-report.html#commentsTue, 10 Jul 2012 00:00:00 -0500adminhttp://www.researchmoz.com/bivalirudin-comprehensive-patent-search-report.html
Original Post Bivalirudin - Comprehensive patent search
source Researchmoz]]>
Original Post Bivalirudin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/bivalirudin-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/mdv-3100-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/mdv-3100-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/mdv-3100-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post MDV-3100 - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post MDV-3100 - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/mdv-3100-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/lurasidone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/lurasidone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lurasidone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Lurasidone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Lurasidone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/lurasidone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/nintedanib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/nintedanib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/nintedanib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Nintedanib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Nintedanib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/nintedanib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/varespladib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/varespladib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/varespladib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Varespladib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Varespladib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/varespladib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/dalcetrapib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/dalcetrapib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/dalcetrapib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Dalcetrapib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Dalcetrapib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/dalcetrapib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/carfilzomib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/carfilzomib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/carfilzomib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Carfilzomib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Carfilzomib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/carfilzomib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/mdv-3100-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/mdv-3100-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/mdv-3100-comprehensive-patent-search-report.html
Original Post MDV-3100 - Comprehensive patent search
source Researchmoz]]>
Original Post MDV-3100 - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/mdv-3100-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/lurasidone-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/lurasidone-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lurasidone-comprehensive-patent-search-report.html
Original Post Lurasidone - Comprehensive patent search
source Researchmoz]]>
Original Post Lurasidone - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/lurasidone-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/nintedanib-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/nintedanib-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/nintedanib-comprehensive-patent-search-report.html
Original Post Nintedanib - Comprehensive patent search
source Researchmoz]]>
Original Post Nintedanib - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/nintedanib-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/lisdexamfetamine-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/lisdexamfetamine-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/lisdexamfetamine-comprehensive-patent-search-report.html
Original Post Lisdexamfetamine - Comprehensive patent search
source Researchmoz]]>
Original Post Lisdexamfetamine - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/lisdexamfetamine-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/clofarabine-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/clofarabine-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/clofarabine-comprehensive-patent-search-report.html
Original Post Clofarabine - Comprehensive patent search
source Researchmoz]]>
Original Post Clofarabine - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/clofarabine-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/abiraterone-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/abiraterone-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/abiraterone-comprehensive-patent-search-report.html
Original Post Abiraterone - Comprehensive patent search
source Researchmoz]]>
Original Post Abiraterone - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/abiraterone-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/daptomycin-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/daptomycin-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/daptomycin-comprehensive-patent-search-report.html
Original Post Daptomycin - Comprehensive patent search
source Researchmoz]]>
Original Post Daptomycin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/daptomycin-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/ixabepilone-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/ixabepilone-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/ixabepilone-comprehensive-patent-search-report.html
Original Post Ixabepilone - Comprehensive patent search
source Researchmoz]]>
Original Post Ixabepilone - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/ixabepilone-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/iloprost-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/iloprost-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/iloprost-comprehensive-patent-search-report.html
Original Post Iloprost - Comprehensive patent search
source Researchmoz]]>
Original Post Iloprost - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/iloprost-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/rilpivirine-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/rilpivirine-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/rilpivirine-comprehensive-patent-search-report.html
Original Post Rilpivirine - Comprehensive patent search
source Researchmoz]]>
Original Post Rilpivirine - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/rilpivirine-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/boceprevir-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/boceprevir-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/boceprevir-comprehensive-patent-search-report.html
Original Post Boceprevir - Comprehensive patent search
source Researchmoz]]>
Original Post Boceprevir - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/boceprevir-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/telaprevir-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/telaprevir-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/telaprevir-comprehensive-patent-search-report.html
Original Post Telaprevir - Comprehensive patent search
source Researchmoz]]>
Original Post Telaprevir - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/telaprevir-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/saxaglitpin-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/saxaglitpin-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/saxaglitpin-comprehensive-patent-search-report.html
Original Post Saxaglitpin - Comprehensive patent search
source Researchmoz]]>
Original Post Saxaglitpin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/saxaglitpin-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/plerixafor-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/plerixafor-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/plerixafor-comprehensive-patent-search-report.html
Original Post Plerixafor - Comprehensive patent search
source Researchmoz]]>
Original Post Plerixafor - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/plerixafor-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/varespladib-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/varespladib-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/varespladib-comprehensive-patent-search-report.html
Original Post Varespladib - Comprehensive patent search
source Researchmoz]]>
Original Post Varespladib - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/varespladib-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/dalcetrapib-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/dalcetrapib-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/dalcetrapib-comprehensive-patent-search-report.html
Original Post Dalcetrapib - Comprehensive patent search
source Researchmoz]]>
Original Post Dalcetrapib - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/dalcetrapib-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/carfilzomib-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/carfilzomib-comprehensive-patent-search-report.html#commentsSat, 12 May 2012 00:00:00 -0500adminhttp://www.researchmoz.com/carfilzomib-comprehensive-patent-search-report.html
Original Post Carfilzomib - Comprehensive patent search
source Researchmoz]]>
Original Post Carfilzomib - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/carfilzomib-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/apixaban-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/apixaban-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/apixaban-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Apixaban - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Apixaban - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/apixaban-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/gatifloxacin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/gatifloxacin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/gatifloxacin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Gatifloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Gatifloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/gatifloxacin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/tafluprost-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/tafluprost-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/tafluprost-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Tafluprost - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Tafluprost - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/tafluprost-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/cabazitaxel-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/cabazitaxel-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/cabazitaxel-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Cabazitaxel - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Cabazitaxel - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/cabazitaxel-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/roflumilast-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/roflumilast-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/roflumilast-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Roflumilast - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Roflumilast - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/roflumilast-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/ridaforolimus-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/ridaforolimus-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/ridaforolimus-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Ridaforolimus - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Ridaforolimus - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/ridaforolimus-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/apixaban-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/apixaban-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/apixaban-comprehensive-patent-search-report.html
Original Post Apixaban - Comprehensive patent search
source Researchmoz]]>
Original Post Apixaban - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/apixaban-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/gatifloxacin-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/gatifloxacin-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/gatifloxacin-comprehensive-patent-search-report.html
Original Post Gatifloxacin - Comprehensive patent search
source Researchmoz]]>
Original Post Gatifloxacin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/gatifloxacin-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/palivizumab-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/palivizumab-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/palivizumab-comprehensive-patent-search-report.html
Original Post Palivizumab - Comprehensive patent search
source Researchmoz]]>
Original Post Palivizumab - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/palivizumab-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/tafluprost-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/tafluprost-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/tafluprost-comprehensive-patent-search-report.html
Original Post Tafluprost - Comprehensive patent search
source Researchmoz]]>
Original Post Tafluprost - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/tafluprost-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/cabazitaxel-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/cabazitaxel-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/cabazitaxel-comprehensive-patent-search-report.html
Original Post Cabazitaxel - Comprehensive patent search
source Researchmoz]]>
Original Post Cabazitaxel - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/cabazitaxel-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/roflumilast-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/roflumilast-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/roflumilast-comprehensive-patent-search-report.html
Original Post Roflumilast - Comprehensive patent search
source Researchmoz]]>
Original Post Roflumilast - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/roflumilast-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/ridaforolimus-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/ridaforolimus-comprehensive-patent-search-report.html#commentsMon, 26 Mar 2012 00:00:00 -0500adminhttp://www.researchmoz.com/ridaforolimus-comprehensive-patent-search-report.html
Original Post Ridaforolimus - Comprehensive patent search
source Researchmoz]]>
Original Post Ridaforolimus - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/ridaforolimus-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/retigabine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/retigabine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 31 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/retigabine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Retigabine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Retigabine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/retigabine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/telavancin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/telavancin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 31 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/telavancin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Telavancin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Telavancin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/telavancin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/fidaxomicin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/fidaxomicin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsTue, 31 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/fidaxomicin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Fidaxomicin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Fidaxomicin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/fidaxomicin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/ceftaroline-fosamil--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/ceftaroline-fosamil--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 30 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/ceftaroline-fosamil--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Ceftaroline Fosamil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Ceftaroline Fosamil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/ceftaroline-fosamil--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/cefixime--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/cefixime--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 30 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/cefixime--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Cefixime - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Cefixime - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/cefixime--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/eslicarbazepine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/eslicarbazepine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 30 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/eslicarbazepine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Eslicarbazepine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Eslicarbazepine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/eslicarbazepine--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/ambrisentan--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/ambrisentan--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsMon, 30 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/ambrisentan--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Ambrisentan - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Ambrisentan - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/ambrisentan--key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/ceftaroline-fosamil--comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/ceftaroline-fosamil--comprehensive-patent-search-report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/ceftaroline-fosamil--comprehensive-patent-search-report.html
Original Post Ceftaroline Fosamil - Comprehensive patent search
source Researchmoz]]>
Original Post Ceftaroline Fosamil - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/ceftaroline-fosamil--comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/cefixime-comprehensive-patent-search-report.htmlhttp://www.researchmoz.com/cefixime-comprehensive-patent-search-report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/cefixime-comprehensive-patent-search-report.html
Original Post Cefixime - Comprehensive patent search
source Researchmoz]]>
Original Post Cefixime - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/cefixime-comprehensive-patent-search-report.html/feed0 http://www.researchmoz.com/eslicarbazepine-comprehensive-patent-search--report.htmlhttp://www.researchmoz.com/eslicarbazepine-comprehensive-patent-search--report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/eslicarbazepine-comprehensive-patent-search--report.html
Original Post Eslicarbazepine - Comprehensive patent search
source Researchmoz]]>
Original Post Eslicarbazepine - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/eslicarbazepine-comprehensive-patent-search--report.html/feed0 http://www.researchmoz.com/ambrisentan-comprehensive-patent-search--report.htmlhttp://www.researchmoz.com/ambrisentan-comprehensive-patent-search--report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/ambrisentan-comprehensive-patent-search--report.html
Original Post Ambrisentan - Comprehensive patent search
source Researchmoz]]>
Original Post Ambrisentan - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/ambrisentan-comprehensive-patent-search--report.html/feed0 http://www.researchmoz.com/retigabine-comprehensive-patent-search--report.htmlhttp://www.researchmoz.com/retigabine-comprehensive-patent-search--report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/retigabine-comprehensive-patent-search--report.html
Original Post Retigabine - Comprehensive patent search
source Researchmoz]]>
Original Post Retigabine - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/retigabine-comprehensive-patent-search--report.html/feed0 http://www.researchmoz.com/telavancin-comprehensive-patent-search--report.htmlhttp://www.researchmoz.com/telavancin-comprehensive-patent-search--report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/telavancin-comprehensive-patent-search--report.html
Original Post Telavancin - Comprehensive patent search
source Researchmoz]]>
Original Post Telavancin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/telavancin-comprehensive-patent-search--report.html/feed0 http://www.researchmoz.com/fidaxomicin-comprehensive-patent-search--report.htmlhttp://www.researchmoz.com/fidaxomicin-comprehensive-patent-search--report.html#commentsFri, 20 Jan 2012 00:00:00 -0600adminhttp://www.researchmoz.com/fidaxomicin-comprehensive-patent-search--report.html
Original Post Fidaxomicin - Comprehensive patent search
source Researchmoz]]>
Original Post Fidaxomicin - Comprehensive patent search
source Researchmoz]]>http://www.researchmoz.com/fidaxomicin-comprehensive-patent-search--report.html/feed0 http://www.researchmoz.com/abacavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/abacavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/abacavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Abacavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Abacavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/abacavir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/acitretin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/acitretin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/acitretin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Acitretin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Acitretin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/acitretin-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/adalimumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/adalimumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/adalimumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Adalimumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Adalimumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/adalimumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/adefovir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/adefovir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/adefovir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/adefovir-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/alendronic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/alendronic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/alendronic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Alendronic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Alendronic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/alendronic-acid-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/alendronic-acid-ext-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/alendronic-acid-ext-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/alendronic-acid-ext-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Alendronic Acid (Ext) - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Alendronic Acid (Ext) - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/alendronic-acid-ext-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/alverine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/alverine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/alverine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Alverine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Alverine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/alverine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/amphotericin-b-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/amphotericin-b-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/amphotericin-b-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Amphotericin B - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Amphotericin B - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/amphotericin-b-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/aripiprazole-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/aripiprazole-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/aripiprazole-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Aripiprazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Aripiprazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/aripiprazole-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/armodafinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/armodafinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/armodafinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Armodafinil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Armodafinil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/armodafinil-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/atovaquone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/atovaquone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/atovaquone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Atovaquone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Atovaquone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/atovaquone-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/azelastine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/azelastine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/azelastine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Azelastine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Azelastine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/azelastine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/barnidipine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/barnidipine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/barnidipine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Barnidipine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Barnidipine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/barnidipine-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0 http://www.researchmoz.com/bevacizumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.htmlhttp://www.researchmoz.com/bevacizumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html#commentsThu, 01 Dec 2011 00:00:00 -0600adminhttp://www.researchmoz.com/bevacizumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html
Original Post Bevacizumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>
Original Post Bevacizumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
source Researchmoz]]>http://www.researchmoz.com/bevacizumab-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage-report.html/feed0